Back
ESC Premium Access

Poster Session 7 - Heart Failure Basic Science

Event: ESC CONGRESS 2019
Topic: European Society of Cardiology
Session type: Poster Session
Date: 3 September 2019

Congress Session

0
9 presentations in this session

Impact of left-ventricular hemodynamics on treadmill exercise intolerance in conscious rats: Pilot evaluation in animals with diastolic dysfunction

Speaker: Doctor B. Ferguson (South San Francisco, US)
Access
Abstract
Slides
0
Thumbnail

Subcutaneous delivery of NPA7, first-in-class novel bispecific designer peptide: enhances cardiorenal function and suppresses renin and aldosterone in vivo and in vitro

Speaker: Doctor S. Sugihara (Rochester, US)
Access
Abstract
Slides
0
Thumbnail

Volume overload-triggered pathological myocardial remodeling occurs in the absence of calcium/calmodulin-dependent protein kinase type II delta

Speaker: Doctor M. Elkenani (Gottingen, DE)
Access
Abstract
Slides
0
Thumbnail

Chronic cardiac allograft rejection after heterotopic rat heart transplantation: ed-a but not ed-b domain containing fibronectin as novel serum biomarker of cardiac allograft vasculopathy

Speaker: Professor M. Franz (Jena, DE)
Access
Abstract
0
Thumbnail

Purinergic receptor Y6 (P2Y6) deficiency impairs left ventricular function

Speaker: Mr I. Schaefer (Basel, CH)
Access
Abstract
0
Thumbnail

Wireless optogenetic inhibition of cardiac sympathetic nerve activity to improve cardiac function and remodeling in chronic post-infarction canines

Speaker: Professor L. Yu (Wuhan, CN)
Access
Abstract
Slides
0
Thumbnail

Phospholamban antisense oligonucleotides drive the reversal of cardiac dysfunction and multiple heart failure parameters during murine dilated cardiomyopathy.

Speaker: Doctor K. Hansson (Mölndal, SE)
Access
Abstract
0
Thumbnail

Inflammation mitigation improves post-infarction functional recovery of the heart.

Speaker: Miss M. Ivanov (Chisinau, MD)
Access
Abstract
Slides
0
Thumbnail

Impact of diabetes on serum biomarkers in heart failure with preserved ejection fraction: insights from the spironolactone for heart failure with preserved ejection fraction (TOPCAT) trial

Speaker: Doctor C. De Marco (Montreal, CA)
Access
Abstract
Slides
0
Thumbnail

9 speakers from this session

Doctor Brian Ferguson

MyoKardia, South San Francisco (United States of America)
0 follower

Doctor Shinobu Sugihara

Mayo Clinic, Rochester (United States of America)
0 follower

Doctor Manar Elkenani

University Medical Center of Gottingen (UMG), Gottingen (Germany)
0 follower

Professor Marcus Franz

University Hospital Jena, Jena (Germany)
0 follower

Mr Ibrahim Schaefer

University Hospital Basel, Basel (Switzerland)
0 follower

Professor Lilei Yu

Renmin Hospital of Wuhan University, Wuhan (China)
0 follower

Doctor Kenny Hansson

Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, Mölndal (Sweden)
0 follower

Miss Mihaela Ivanov

Institute of Cardiology of Moldova, Chisinau (Moldova (Republic of))
0 follower

Doctor Corrado De Marco

University of Montreal, Montreal (Canada)
0 follower

This platform is supported by

logo Novo Nordisk